Welcome to our dedicated page for Aperture AC news (Ticker: APUR), a resource for investors and traders seeking the latest updates and insights on Aperture AC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aperture AC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aperture AC's position in the market.
Aperture AC (Nasdaq: APUR) announced that effective June 10, 2026, its units will cease trading and automatically separate into Class A ordinary shares and rights.
The Class A shares and rights will trade separately on the Nasdaq Capital Market under ticker symbols APUR and APURR. No holder action is required.
Aperture AC (Nasdaq: APUR) closed its initial public offering of 10,200,000 units, including 1,200,000 units from a partial over-allotment exercise, at $10.00 per unit, generating $102,000,000 in gross proceeds.
The SPAC’s units trade on the Nasdaq Capital Market under ticker APURU, with shares and rights expected to trade separately as APUR and APURR.
Aperture AC priced its $90 million initial public offering of 9,000,000 units at $10.00 per unit. Units are expected to begin trading on Nasdaq on May 21, 2026 under ticker APURU.
Each unit includes one Class A share and one right to receive one-fourth of a Class A share. Underwriters have a 30‑day option to buy up to 1,350,000 additional units.